home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,144 rows where filing_year = 2021 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • fourth_quarter 299
  • second_quarter 287
  • third_quarter 280
  • first_quarter 278

issue_code 1

  • PHA · 1,144 ✖

filing_year 1

  • 2021 · 1,144 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2591009 STEPHANIE A. BURGESS INC 4680713d-bdad-486c-9d8c-1bde890eb590 1T STEPHANIE A. BURGESS INC 401105595 VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES 2021 first_quarter PHA Issues related to prescription drug importation, fentanyl scheduling, increased funding for law enforcement to combat fentanyl trafficking, combating pill presses, enhanced penalties for wholesale prescription drug trafficking, counterfeit prevention efforts, enforcement against counterfeits, opioid prevention and recovery, WHOIS & Lock and Suspend, Byrne JAG funding. HOUSE OF REPRESENTATIVES,SENATE     0 1 2021-01-20T13:08:09.747000-05:00
2591408 LUNGREN LOPINA LLC 868e1e06-02bf-4f9e-a494-e2810effa5f1 Q1 LUNGREN LOPINA LLC 401103314 AMPAC FINE CHEMICALS 2021 first_quarter PHA Fair treatment for US based pharmaceutical ingredients HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-01T11:46:28.043000-04:00
2591424 PANNONE LOPES DEVEREAUX & O'GARA LLC 68a232a4-7f34-4412-b907-e8f339114120 Q1 PANNONE LOPES DEVEREAUX & O'GARA LLC 401105501 AMGEN 2021 first_quarter PHA Prescription drug pricing.   9000   0 0 2021-04-01T12:42:33.730000-04:00
2592563 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION c9913018-55e0-480d-8a76-b91f74848f9d Q1 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 401103605 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 2021 first_quarter PHA COVID-19 vaccine & therapeutic production, and pandemic protection. Pharmaceutical supply chain and domestic manufacturing HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2021-04-07T13:22:30.830000-04:00
2592654 STONINGTON GLOBAL 7b2241cd-9c84-44ba-995a-7a8ed296f758 Q1 STONINGTON GLOBAL 401105189 SORRENTO THERAPEUTICS, INC. 2021 first_quarter PHA Regulatory approvals and funding for pharmaceutical products and devices Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 150000   0 0 2021-04-07T19:25:57.163000-04:00
2593192 PUBLIC CITIZEN 590cbc34-6857-42cd-917d-6dced46bda70 Q1 PUBLIC CITIZEN 32362 PUBLIC CITIZEN 2021 first_quarter PHA Covid-19 medicine pricing and access, drug price negotiation, biologics exclusivity, NIST legislative package, Pandemic treatment access and affordability act, Pandemic emergency Manufacturing Act, Medicare and Medicaid prescription drug rebates, We PAID act, Empowering Medicare seniors to Negotiate drug Pricing act, global COVID 19 vaccine access, Stop Stalling act, drug price spike excise act, repealing direct to consumer advertisement tax, Stop Price Gouging Act, Preserving access to affordable generics, TRACK act, drug R&D cost transparency, using executive authority to increase vaccine production. Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Securities & Exchange Commission (SEC),SENATE,White House Office   90000 0 0 2021-04-12T08:00:37.127000-04:00
2593277 POLSINELLI PC 208ea6f7-5298-4ccf-8e1e-dfcd3e91e176 Q1 POLSINELLI PC 314911 TEVA PHARMACEUTICALS USA, INC. 2021 first_quarter PHA H.R.1319, American Rescue Plan Act Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products Review of Administration telehealth policies HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-04-12T10:43:48.120000-04:00
2593585 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION db53ffda-1bcd-49c1-b6ef-37fcc1b3c9bf Q1 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2021 first_quarter PHA OTC switch process -- no bill number Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   111000 0 0 2021-04-12T16:32:21.017000-04:00
2593679 PENN AVENUE PARTNERS 8475240c-235b-44ea-b1d8-2e1082e148d1 Q1 PENN AVENUE PARTNERS 400918672 ALKERMES, INC. 2021 first_quarter PHA Regulatory and legislative issues impacting Alkermes. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-12T18:08:27.890000-04:00
2594099 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 99423dd9-ec02-4faf-9401-9838f271af82 1T AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 3446 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 2021 first_quarter PHA american rescue plan, S333(nursing home protection act) S784 Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE   15000 0 1 2021-04-13T12:03:54.090000-04:00
2594343 MCDERMOTT+ LLC ca002339-ad26-4f9c-9d49-5c33678a7060 Q1 MCDERMOTT+ LLC 401103287 ALLIANCE FOR RURAL HOSPITAL ACCESS 2021 first_quarter PHA Amendments to Section 340B of the Public Health Service Act regarding eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-13T15:04:08.467000-04:00
2594426 TODD STRATEGY GROUP 73f46ee9-48c3-45e0-b017-3dcdd86228f3 Q1 TODD STRATEGY GROUP 401103321 ALKERMES, INC. 2021 first_quarter PHA Prescription drug pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-13T15:40:28.267000-04:00
2594433 TODD STRATEGY GROUP 133ce123-779c-4521-9bf3-757a9ecce9ef Q1 TODD STRATEGY GROUP 401103321 ALKERMES, INC. 2021 first_quarter PHA Prescription drug pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-13T15:41:31.293000-04:00
2594496 TODD STRATEGY GROUP ce66acb3-a22f-44dd-af5e-2e576e4272db Q1 TODD STRATEGY GROUP 401103321 BIOTECHNOLOGY INNOVATION ORGANIZATION 2021 first_quarter PHA Drug pricing and access. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office 60000   0 0 2021-04-13T16:28:35.707000-04:00
2594498 TODD STRATEGY GROUP 0d84fe59-83fc-44dc-b9a8-6d47866c8c2b Q1 TODD STRATEGY GROUP 401103321 CAREDX, INC. 2021 first_quarter PHA Immunosuppressive drug coverage implementation. S.3404: VALID Act of 2020. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2021-04-13T16:31:37.003000-04:00
2594507 TODD STRATEGY GROUP ddd69a44-58a5-482c-b533-c868395f6339 Q1 TODD STRATEGY GROUP 401103321 EMD SERONO INC. 2021 first_quarter PHA Drug pricing policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-13T16:34:42.833000-04:00
2594528 TODD STRATEGY GROUP 68340f09-da59-405c-9c99-a292bc9b66d3 Q1 TODD STRATEGY GROUP 401103321 GENENTECH, INC. 2021 first_quarter PHA Prescription drug payment reform. Supply chain. Strategic National Stockpile. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-13T16:46:58.967000-04:00
2594555 TODD STRATEGY GROUP c9b1aa30-084c-4840-a0ff-c7ed7a1dc600 Q1 TODD STRATEGY GROUP 401103321 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2021 first_quarter PHA Drug Pricing and Access. Pharmaceutical Supply Chain. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-13T17:07:19.603000-04:00
2594566 TODD STRATEGY GROUP 1a3dd2ad-ae58-42f4-b1cc-7c3891554d5e Q1 TODD STRATEGY GROUP 401103321 US WORLDMEDS, LLC 2021 first_quarter PHA Opioid Use Disorder Treatment Policy. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-04-13T17:11:27.133000-04:00
2594585 INDEPENDENT PHARMACY COOPERATIVE 891e6b8e-a22f-4e52-8c1a-147a0be717eb Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2021 first_quarter PHA Support regulations/laws that would eliminate pharmacy DIR. IPC supports Pharmacists as providers under Medicare Part B IPC supports Pharmacists as Immunizers IPC supports 340B Program and contract pharmacies IPC supports Federal Retail Pharmacy COVID-19 Vaccination Program expansion. Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   30000 0 0 2021-04-13T17:30:36.723000-04:00
2594633 PENN AVENUE PARTNERS 8010d9f4-1e6e-4e67-bd1e-0b7d9d35b0b3 Q1 PENN AVENUE PARTNERS 400918672 UNITEDHEALTH GROUP, INC. 2021 first_quarter PHA Pharmacy benefit related issues. HOUSE OF REPRESENTATIVES,SENATE,White House Office 90000   0 0 2021-04-13T18:15:51.647000-04:00
2594716 OFF HILL STRATEGIES L.L.C. 73a0b68b-ad92-4b4a-bd28-d062feaca632 Q1 OFF HILL STRATEGIES L.L.C. 401103327 FINANCIAL OVERSIGHT AND MANAGEMENT BOARD FOR PUERTO RICO 2021 first_quarter PHA Monitored pharmaceutical supply chain legislation/ policies HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2021-04-13T21:17:16.137000-04:00
2594801 PARAGON BIOSCIENCES, LLC 055375df-8df2-4ed0-af67-0c54affedfbf Q1 PARAGON BIOSCIENCES, LLC 401105338 PARAGON BIOSCIENCES, LLC 2021 first_quarter PHA Issues related to public and private investment in biosciences and R&D       0 0 2021-04-14T09:33:45.827000-04:00
2595207 AARP 694534f9-e7ee-4036-93f2-3c561b98c3af Q1 AARP 1694 AARP 2021 first_quarter PHA Public L.117-2, American Rescue Plan Act of 2021 No bill number - Discussed vaccine coverage, development, approval, funding, distribution and prioritization No bill number - Discussed vaccine coverage No bill number - Discussed drug pricing reforms, including price negotiation, out-of-pocket cap, and inflation-based rebates Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Corporation for Natl & Community Service,Defense, Dept of (DOD),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Indian Health Service,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Natl Transportation Safety Board (NTSB),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Pension Benefit Guaranty Corporation (PBGC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office   2840000 0 0 2021-04-14T13:14:18.377000-04:00
2595496 CRISPR THERAPEUTICS, INC. dc9ffc56-286e-4c26-9958-dc369654352b Q1 CRISPR THERAPEUTICS, INC. 401105184 CRISPR THERAPEUTICS, INC. 2021 first_quarter PHA Coverage & reimbursement for Cell and Gene Therapies Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2021-04-14T16:19:10.123000-04:00
2595660 ACG ADVOCACY 599487bc-9c8f-41e7-9a42-b0c83c3cd6b4 Q1 ACG ADVOCACY 2057 WALGREEN CO. 2021 first_quarter PHA Drug Pricing Policy Issues. Data privacy and DIR fee reform. Public Health Crisis. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-14T17:34:04.727000-04:00
2595707 RED+BLUE STRATEGIES 2b66b162-e094-4996-910a-f293c218d45a Q1 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2021 first_quarter PHA PL 177-2 - The American Rescue Plan Act - Issues related to increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance. Issues related to Trump-era rules and regulations regarding Medicare rebate policies and PBM transparency. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2021-04-14T18:36:18.757000-04:00
2595709 RED+BLUE STRATEGIES cbae9e21-927d-4c15-8899-cb8858e838b0 Q1 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2021 first_quarter PHA PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 60000   0 0 2021-04-14T19:23:20.097000-04:00
2595721 RED+BLUE STRATEGIES ef115b3f-2775-46fa-81e8-99303d98485c Q1 RED+BLUE STRATEGIES 400693064 COHERUS BIOSCIENCES 2021 first_quarter PHA S. 164 - Biosimilars Education Act of 2021 - A bill to raise awareness of the efficacy and promise of biosimilars in the American health care system. Issues and policies that incent companies to increase their US footprint and adopt Made in America business practices. Policies to help grow the biosimilars marketplace in the United States. Policies focused on improving cancer care through access to affordable treatments. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-14T20:13:24.497000-04:00
2595780 REPUBLIC CONSULTING, LLC 58fedfd2-cdc3-47be-b7cf-2e2b95b60a1f Q1 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2021 first_quarter PHA Monitored Health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-15T08:39:42.810000-04:00
2596177 RUBICON ADVISORS, LLC 39277903-a314-4c12-97bf-a6b91c587cbd Q1 RUBICON ADVISORS, LLC 315091 CONSCIOUS DISCIPLINE 2021 first_quarter PHA Medicare HOUSE OF REPRESENTATIVES,SENATE 67500   0 0 2021-04-15T12:33:29.383000-04:00
2596186 RUBICON ADVISORS, LLC 05b057f0-c693-49bc-a7be-93bf20f1a6e9 Q1 RUBICON ADVISORS, LLC 315091 DYNAVAX TECHNOLOGIES 2021 first_quarter PHA Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA) HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2021-04-15T12:37:32.237000-04:00
2596191 RUBICON ADVISORS, LLC c53959c7-8f0c-49aa-9821-f8baeed37591 Q1 RUBICON ADVISORS, LLC 315091 DR. REDDY'S LABORATORIES, LTD 2021 first_quarter PHA Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 60000   0 0 2021-04-15T12:40:34.080000-04:00
2596193 RUBICON ADVISORS, LLC 23ed0ddd-e69e-45ab-8981-fe10bbaa7abf Q1 RUBICON ADVISORS, LLC 315091 LANNETT COMPANY, INC 2021 first_quarter PHA Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 50000   0 0 2021-04-15T12:42:35.257000-04:00
2596199 RUBICON ADVISORS, LLC e21c6534-833c-407d-84ad-9603aac144e3 Q1 RUBICON ADVISORS, LLC 315091 AVET PHARMACEUTICALS 2021 first_quarter PHA GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES 30000   0 0 2021-04-15T12:44:37.577000-04:00
2596206 RUBICON ADVISORS, LLC d9d0aae7-eddd-42f1-88be-77bea67ef473 Q1 RUBICON ADVISORS, LLC 315091 ASCENDIS PHARMA, INC. 2021 first_quarter PHA Food and Drug Administration, Orphan Drugs Food & Drug Administration (FDA) 60000   0 0 2021-04-15T12:52:40.387000-04:00
2596220 KOUNTOUPES DENHAM CARR & REID, LLC c34b1284-bf9a-49df-9282-aeb1ced07f95 Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2021 first_quarter PHA General issues related to over the counter pharmaceuticals and pharmaceutical supply chain. Implementation of the Over the Counter Monograph provisions included in PL 116-136, Coronavirus Aid, Relief and Economic Security Act. Issues related to supplements. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-15T13:00:43.103000-04:00
2596229 RUBICON ADVISORS, LLC 36819046-18f6-4d15-a565-f1b753316192 Q1 RUBICON ADVISORS, LLC 315091 HYPOPARATHYROIDISM ASSOCIATION 2021 first_quarter PHA Rare disease issues Orphan drugs Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS)     0 0 2021-04-15T13:13:47.003000-04:00
2596325 KOUNTOUPES DENHAM CARR & REID, LLC 0683667d-8c1b-4b48-bf61-8f2dff90561e Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 GLENMARK PHARMACEUTICALS, INC., USA 2021 first_quarter PHA Issues related to H.R. 1319, the American Rescue Plan. Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-15T14:00:18.890000-04:00
2596389 AMERICAN COLLEGE OF CLINICAL PHARMACY 6471f83a-97bc-4294-b1b9-1a5a742d00ca Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2021 first_quarter PHA Coverage for direct patient care services of qualified clinical pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2021-04-15T14:34:43.143000-04:00
2596671 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 48c32028-ee05-482f-8820-3818f45f78e1 Q1 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2021 first_quarter PHA 340B Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   30890 0 0 2021-04-15T17:01:11.273000-04:00
2596713 TODD STRATEGY GROUP b2021dbe-509a-4bdf-85a2-6ae15d211807 Q1 TODD STRATEGY GROUP 401103321 BAYER CORPORATION 2021 first_quarter PHA Drug pricing. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-15T17:37:23.930000-04:00
2596779 BROYDRICK & ASSOCIATES 41e2423a-fc21-4068-b974-eb130f4f3bc7 Q1 BROYDRICK & ASSOCIATES 7268 EXELA PHARMA SCIENCES 2021 first_quarter PHA Drug shortages and FDA approval, USTR acceptance. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-04-15T18:43:47.097000-04:00
2596794 BROYDRICK & ASSOCIATES dc7c05b4-3a58-4f49-a6e5-b769197bdaec Q1 BROYDRICK & ASSOCIATES 7268 TONIX PHARMACEUTICALS 2021 first_quarter PHA Funding new drug for PTSD and COVID 19. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-04-15T18:57:53.827000-04:00
2597157 ASSOCIATION FOR ACCESSIBLE MEDICINES 909fc0f9-87cd-4873-8016-70be99794c19 Q1 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2021 first_quarter PHA Prescription Drug Costs. Drug Pricing. Pharmaceutical Exclusivity. 180-Day Exclusivity. Forfeiture of 180-Day Exclusivity. 12-Year Exclusivity. Contract Genericization. 30-Month Stays. Labeling of Generic Drugs and Biosimilars. Modern Labeling. Generic carveouts patent protected information in drug labels, including issues related to GSK v. Teva. Orange Book. Drug Shortages. S.917: Short on Competition Act. Stockpile of Generic Drugs. Generic Drug User Fee Amendments (GDUFA). GDUFA III Negotiations. Biosimilar User Fee Act (BsUFA). BsUFA III Negotiations. Biosimilars Naming. Biosimilars Insulin. Pass-through Payments for Biosimilars. Cost Sharing for Biosimilars. Implementation of Food and Drug Administration Reauthorization Act (FDARA). FDA Inspections. Buy American Proposals. Issues Related to COVID-19. Secretary Azar Importation Plan. Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,U.S. Trade Representative (USTR)   880000 0 0 2021-04-16T10:45:32.463000-04:00
2597415 4C COMMUNICATIONS, INC. 9a6e19a7-28cf-4f45-b74a-7aeca10daf3d Q1 4C COMMUNICATIONS, INC. 323717 HEALTHCARE LEADERSHIP COUNCIL 2021 first_quarter PHA The Treat Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-04-16T12:03:35.603000-04:00
2597556 MARSHALL & POPP, LLC 793b15c0-d92b-435b-a479-a19d8de96d22 Q1 MARSHALL & POPP, LLC 401105121 AMGEN USA INC. 2021 first_quarter PHA Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including: *S.Con.Res. 5, fiscal year 2021 budget resolution. *H.R.1319: American Rescue Plan Act of 2021. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-16T12:21:06.410000-04:00
2597626 MARSHALL & POPP, LLC 225badc0-c273-4915-8109-09282cef5b3e Q1 MARSHALL & POPP, LLC 401105121 GENENTECH, INC. 2021 first_quarter PHA Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including: *S.Con.Res. 5, fiscal year 2021 budget resolution. *H.R.1319: American Rescue Plan Act of 2021. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-16T12:34:21.377000-04:00
2597701 COVINGTON & BURLING LLP 1a7fc91c-e94c-4a23-95da-396923f74a50 Q1 COVINGTON & BURLING LLP 11195 1776 PHARMACEUTICALS LLC 2021 first_quarter PHA Re-shoring production of essential medicine HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-04-16T12:52:39.027000-04:00
2597801 MARSHALL & POPP, LLC 6d4d623b-b4d9-4da9-9feb-a24fb29f3119 Q1 MARSHALL & POPP, LLC 401105121 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2021 first_quarter PHA Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including: *S.Con.Res. 5, fiscal year 2021 budget resolution. *H.R.1319: American Rescue Plan Act of 2021. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-16T13:27:04.867000-04:00
2597815 MARSHALL & POPP, LLC d111e75f-230f-431c-b266-4aede4ec97aa Q1 MARSHALL & POPP, LLC 401105121 SANOFI U.S. SERVICES, INC. 2021 first_quarter PHA Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including: *S.Con.Res. 5, fiscal year 2021 budget resolution. *H.R.1319: American Rescue Plan Act of 2021. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-16T13:30:08.670000-04:00
2597865 LINCOLN PARK GROUP L.L.C. a80ddce7-0f63-434f-905d-99774a2418ca Q1 LINCOLN PARK GROUP L.L.C. 401104374 CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2021 first_quarter PHA Support for S. 920/H.R. 2181 - A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals and S. 259/H.R. 832 - Safe and Affordable Drugs from Canada Act; issues related to personal drug importation. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-16T13:44:24.673000-04:00
2597881 SUMMIT PUBLIC AFFAIRS fd4a8886-3e6e-4359-bffd-fa337a0f7928 Q1 SUMMIT PUBLIC AFFAIRS 401105467 VANDA PHARMACEUTICALS INC. 2021 first_quarter PHA Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. COVID-19 clinical trials. H.R. 1319, American Rescue Plan Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-16T13:47:28.867000-04:00
2598015 HOGAN LOVELLS US LLP de129df1-52e8-4a53-bdb0-6a8b37171f16 Q1 HOGAN LOVELLS US LLP 18422 ALVOGEN, PHARMA US, INC. 2021 first_quarter PHA Issues related to COVID-19 HOUSE OF REPRESENTATIVES,SENATE 410000   0 0 2021-04-16T14:20:07.040000-04:00
2598225 FAEGRE DRINKER BIDDLE & REATH LLP 27f32965-aec6-49ad-a10a-ea51172baac9 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 NATIONAL ASSOCIATION OF BOARDS OF PHARMACY 2021 first_quarter PHA Medication safety, pharmacy regulation, and the opioid epidemic; prescription drug monitoring programs; COVID-19 response; H.R. 2482, S. 2074 - Mainstreaming Addiction Treatment Act; opposing prescription drug importation. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-16T15:15:09.617000-04:00
2598227 FAEGRE DRINKER BIDDLE & REATH LLP 6b7b95f1-93e0-42b4-b790-5891b884acf3 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) 2021 first_quarter PHA Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS; Communications Decency Act, Section 230 reform; STOP Act implementation. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 70000   0 0 2021-04-16T15:16:10.457000-04:00
2598280 BUCHANAN INGERSOLL & ROONEY PC 33901d14-3e95-465d-a483-10b6d44c3d57 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2021 first_quarter PHA Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-16T15:31:24.800000-04:00
2598297 340B HEALTH 0ecd5a64-dafe-4d76-93cf-aeeaab5cb39e Q1 340B HEALTH 316434 340B HEALTH 2021 first_quarter PHA The 340B Drug Pricing Program; S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R. 853: Closing Loopholes for Orphan Drugs Act; H.R.1319 - American Rescue Plan Act of 2021. Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   292698 0 0 2021-04-16T15:36:30.673000-04:00
2598311 BLUECROSS BLUESHIELD OF TENNESSEE f502cd90-ea26-424c-bd91-997ae3000703 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2021 first_quarter PHA COVID-19 Testing; Vaccine Strategy and Treatment HOUSE OF REPRESENTATIVES,SENATE   351297 0 0 2021-04-16T15:39:35.877000-04:00
2598440 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS fe311a0f-ea2d-4613-b919-45fc27ad65b3 Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2021 first_quarter PHA Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Conversation with DEA regulation on Medication-Assisted Treatment and drug shortages. Discussed COVID-19 response recommendations with House and Senate Offices, HHS and its subagencies, and DEA. Contact HHS, House and Senate Offices concerning rule enforcement of the 340B Drug Pricing Program. Contact FDA concerning the practice of White Bagging and Brown Bagging patient medications. Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   310000 0 0 2021-04-16T16:07:12.943000-04:00
2598588 MASSACHUSETTS MEDICAL SOCIETY 223f495c-19fb-4af8-8015-8c1fe970734a Q1 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2021 first_quarter PHA Issues related to prescription drug prices - no specific bill Issues related to vaccines - no specific bill Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2021-04-16T16:49:47.173000-04:00
2598796 BLUECROSS BLUESHIELD OF TENNESSEE fbdead67-adcb-4d3e-9980-1e054b0b2330 1A BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2021 first_quarter PHA COVID-19 Testing; Vaccine Strategy and Treatment HOUSE OF REPRESENTATIVES,SENATE   350000 0 0 2021-04-16T17:59:32.857000-04:00
2599018 FORBES-TATE 25f1bd84-095b-49e4-8725-cd484aa89f12 Q1 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2021 first_quarter PHA Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-17T10:29:10.167000-04:00
2599084 FORBES-TATE 67276655-f868-4b30-9392-33391cddc53c Q1 FORBES-TATE 400976792 MERCK 2021 first_quarter PHA Issues related to prescription drug pricing, vaccines, animal health, and maternal health. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-17T11:12:47.640000-04:00
2599142 FORBES-TATE c45a85a5-7815-4ba8-85b4-8f86ad517cf9 Q1 FORBES-TATE 400976792 PHRMA 2021 first_quarter PHA Issues pertaining to prescription drug pricing. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-04-17T11:50:36.587000-04:00
2599499 CAPITOL COUNSEL LLC 2cd7ef58-319c-451b-8926-f14c507f2530 Q1 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2021 first_quarter PHA Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-17T16:34:23.210000-04:00
2599516 CAPITOL COUNSEL LLC 0f806121-a039-4450-bcfb-bda78c063649 Q1 CAPITOL COUNSEL LLC 313715 VERTEX PHARMACEUTICALS INCORPORATED 2021 first_quarter PHA Monitoring and advocacy on matters related to the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-17T16:47:26.777000-04:00
2599661 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 22d83402-0f3c-4a0b-926e-eba44effe71e Q1 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2021 first_quarter PHA Compounding, preparation, packaging and dispensing of radiopharmaceuticals Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE   48000 0 0 2021-04-18T08:52:14.947000-04:00
2599793 TARPLIN, DOWNS & YOUNG, LLC 91ea6662-58e6-4931-8fa9-25f6d1ae1d06 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2021 first_quarter PHA Drug coverage & reimbursement vaccination no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-04-18T13:30:57.280000-04:00
2599824 KOUNTOUPES DENHAM CARR & REID, LLC fcee1c35-ff3a-48d0-9d46-d2f208ec2d2e Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) 2021 first_quarter PHA Issues related to generic pharmaceuticals and biosimilars, including H.R. 928, the BLOCKING Act of 2019. Reimbursement rate for biosimilars. Issues related to the implementation of H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021. Issues related to H.R. 1319, The American Rescue Plan. Issues related to the pharmaceutical supply chain and domestic manufacturing. Issues related to H.R. 6179, Increasing Access to Biosimilars Act of 2020, H.R. 4597, the ACCESS Act, and H.R. 4455, the Biosim Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-18T14:12:06.457000-04:00
2600017 TARPLIN, DOWNS & YOUNG, LLC 032f8b9b-f73f-4c9f-87a1-23e8e65dc8ca Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2021 first_quarter PHA H.R. 1319, American Rescue Plan of 2021 no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2021-04-18T17:59:55.807000-04:00
2600242 VAN SCOYOC ASSOCIATES a0fe9715-3350-46ad-a625-b65c203df59e Q1 VAN SCOYOC ASSOCIATES 39837 ZEBRA TECHNOLOGIES CORP. 2021 first_quarter PHA Temperature monitoring technology for COVID-19 vaccines, generally Public Law 117-7, American Rescue Plan Act of 2021, Temperature monitoring technology HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-19T06:21:57.887000-04:00
2600780 ELI LILLY AND COMPANY 6a80140a-417f-423f-a5cd-0469b2babcad Q1 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2021 first_quarter PHA Hospital discounts; 340B program Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   1840000 0 0 2021-04-19T09:47:49.270000-04:00
2601148 UNIVERSITY OF IOWA 6a5bed25-7edc-4377-b284-bc2514dda0d9 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2021 first_quarter PHA N/A Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE   80000 0 0 2021-04-19T10:34:06.737000-04:00
2601523 GOVERNMENT COUNSEL, LLC 42b7162e-1b5c-4b3e-9666-4575d657af20 Q1 GOVERNMENT COUNSEL, LLC 401105070 HEALTHCARE DISTRIBUTION ALLIANCE 2021 first_quarter PHA H.R. 768-Block, Report, And Suspend Suspicious Shipments Act of 2021; DEA Proposed Rule on Suspicious Orders of Controlled Substances [85 Fed. Reg. 69282 (November 2, 2020)] Docket No. DEA-437; General issues relating to implementation of Public Law 113-54 (DSCSA). HOUSE OF REPRESENTATIVES 60000   0 0 2021-04-19T11:03:31.833000-04:00
2601600 HANCE SCARBOROUGH 13322c89-3761-467b-8c41-7ecfd0dc2cab Q1 HANCE SCARBOROUGH 17443 PHRMA 2021 first_quarter PHA Patent reform regarding pharmaceutical research & products. SENATE 30000   0 0 2021-04-19T11:09:54.877000-04:00
2602328 ELI LILLY AND COMPANY 42caff2d-ddac-4d83-9061-bc8f0ff3af25 1A ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2021 first_quarter PHA Hospital discounts; 340B program Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   1840000 0 0 2021-04-19T12:08:02.790000-04:00
2602619 BAVARIAN NORDIC INC. 5a342a79-36e2-44cb-8a10-ff6a580fc84d Q1 BAVARIAN NORDIC INC. 312257 BAVARIAN NORDIC INC. 2021 first_quarter PHA Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; cancer; PAHPA; Labor-HHS-ED appropriations bills HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2021-04-19T12:32:07.477000-04:00
2602885 THERMO FISHER SCIENTIFIC INC. 8ad55cb6-b5ac-40aa-93f8-fcc7a2041fb7 Q1 THERMO FISHER SCIENTIFIC INC. 323251 THERMO FISHER SCIENTIFIC INC 2021 first_quarter PHA Worker training program. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Food & Drug Administration (FDA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   1300000 0 0 2021-04-19T13:02:11.220000-04:00
2603115 NATIONAL RURAL HEALTH ASSOCATION c0186c1b-583d-477b-8fcc-c1440e8dd456 Q1 NATIONAL RURAL HEALTH ASSOCATION 53048 NATIONAL RURAL HEALTH ASSOCATION 2021 first_quarter PHA The 340B Program and drug pricing Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE   76501 0 0 2021-04-19T13:23:09.367000-04:00
2603310 TARPLIN, DOWNS & YOUNG, LLC b744236c-31ab-493b-8f9e-e553b790cbca Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2021 first_quarter PHA Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting (HR 768) Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-04-19T13:43:53.997000-04:00
2603571 HANCE SCARBOROUGH dc63d2d7-9fcd-4e6e-9f97-562c841e9565 Q1 HANCE SCARBOROUGH 17443 ALLIANCE FOR PHARMACY COMPOUNDING 2021 first_quarter PHA Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2022 Appropriations HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-19T14:13:01.597000-04:00
2603864 HANCE SCARBOROUGH 146e34f8-2d8c-47c0-9c7a-5e0cf7880680 Q1 HANCE SCARBOROUGH 17443 BOEHRINGER INGELHEIM USA CORPORATION 2021 first_quarter PHA Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-04-19T14:36:24.553000-04:00
2603998 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 16b62b4d-acb3-47d4-a30e-0302ecf7c059 Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2021 first_quarter PHA Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) Block, Report, and Suspend Suspicious Shipments Act of 2021 (HR 768) Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   278719 0 0 2021-04-19T14:43:53.827000-04:00
2604078 BUCHANAN INGERSOLL & ROONEY PC 76ae5829-d1a0-4e6c-bb41-4a08bf881d0e 1T BUCHANAN INGERSOLL & ROONEY PC 55291 PHARMACEUTICAL ASSOCIATES, INC. 2021 first_quarter PHA Strategy development and implementation of company's federal government relations initiatives. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2021-04-19T14:50:16.577000-04:00
2604277 WAXMAN STRATEGIES 2944f5ad-0b3d-4be3-903f-ae72f9a2ef29 Q1 WAXMAN STRATEGIES 401103693 340B HEALTH 2021 first_quarter PHA Issues affecting the 340B drug pricing program; Appropriations for 340B program. HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2021-04-19T15:08:06.547000-04:00
2604501 M.J. SIMON & COMPANY, LLC 0a5e098f-5cd4-49e4-80e9-c39f4acb74c4 Q1 M.J. SIMON & COMPANY, LLC 40026223 NOBELPHARMA AMERICA 2021 first_quarter PHA FDA inspections HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2021-04-19T15:27:01.557000-04:00
2604528 WINNING STRATEGIES WASHINGTON 643af1d6-0730-484e-990c-1cdbda9fbfc6 Q1 WINNING STRATEGIES WASHINGTON 50796 KALEO 2021 first_quarter PHA Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues Federal Emergency Management Agency (FEMA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-19T15:29:08.120000-04:00
2604595 BOCKORNY GROUP, INC. 8dda7526-a7a7-4642-8468-2dd9bd94edd9 Q1 BOCKORNY GROUP, INC. 289773 CVS HEALTH INC 2021 first_quarter PHA Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021 Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 80000   0 0 2021-04-19T15:34:22.953000-04:00
2604874 ARTEMIS POLICY GROUP LLC 3007b2f3-a7a7-4b40-9a8a-a05942519174 Q1 ARTEMIS POLICY GROUP LLC 401105617 AMERICAN SOCIETY OF HEMATOLOGY 2021 first_quarter PHA FDA policies related to research and approvals of treatments for hematological diseases Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2021-04-19T15:55:19.570000-04:00
2604942 ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) b32fcda3-af9a-432c-b213-52673bc01718 Q1 ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) 400762305 AMERISOURCEBERGEN CORPORATION 2021 first_quarter PHA Issues related to drug pricing and transparency, generally. Issues related to the importation of prescription medicines Issues related to the pharmaceutical supply chain and stockpiling Issues related to COVID vaccine distribution HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-04-19T15:58:34.120000-04:00
2604945 ARTEMIS POLICY GROUP LLC 2c5aa288-94f7-4cca-a6ce-47af877529e5 Q1 ARTEMIS POLICY GROUP LLC 401105617 THE HEMOPHILIA ALLIANCE 2021 first_quarter PHA Issues related to participation in the 340B Drug Discount Program Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 42000   0 0 2021-04-19T15:58:34.607000-04:00
2605002 ARTEMIS POLICY GROUP LLC af14d68b-14fd-4232-a1bb-5adade1829e7 Q1 ARTEMIS POLICY GROUP LLC 401105617 NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) 2021 first_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Natl Institutes of Health (NIH),SENATE 51000   0 0 2021-04-19T16:02:48.210000-04:00
2605105 MUSCULAR DYSTROPHY ASSOCIATION, INC. 06672678-0605-437c-852f-8bad538c1d8a Q1 MUSCULAR DYSTROPHY ASSOCIATION, INC. 400348610 MUSCULAR DYSTROPHY ASSOCIATION, INC. 2021 first_quarter PHA Advocated for provisions that enable ongoing access to necessary medications and treatments for neuromuscular disease patients throughout theCOVID-19 pandemic. Advocated for the reintroduction of the ACT for ALS, legislation that should accelerate development of treatments for individuals with ALS and other neuromuscular diseases. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)   100000 0 0 2021-04-19T16:10:09.200000-04:00
2605299 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH f18992dd-f902-4265-b1c7-53a4176d2965 Q1 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH 401104060 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH 2021 first_quarter PHA General education around pharmaceuticals related to Parkinson's disease Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   25000 0 0 2021-04-19T16:23:48.927000-04:00
2605459 NATIONAL ASSOCIATION OF CHAIN DRUG STORES fe851c86-99df-4ddf-a9d3-f457b2853686 Q1 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2021 first_quarter PHA Interfaced with the White House, Operation Warp Speed; HHS Secretary and team, and CDC to drive COVID testing & vaccinations across the nation. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   195000 0 0 2021-04-19T16:37:30.117000-04:00
2605951 MEHLMAN CONSULTING, INC. 2b5ea278-8ae5-4753-a541-dede1cadfa42 Q1 MEHLMAN CONSULTING, INC. 284950 AMNEAL 2021 first_quarter PHA Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2021-04-19T17:13:19.467000-04:00
2606005 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 30546d6e-a17f-4576-9750-18caebae1a77 Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2021 first_quarter PHA S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021; Draft legislation, Vaccine Injury Compensation Modernization; COVID vaccine distribution Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   360000 0 0 2021-04-19T17:19:31.493000-04:00
2606080 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 2bc7e58c-f11c-47be-873b-8db933b366ae Q1 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 323876 BLUE CROSS AND BLUE SHIELD OF KANSAS INC 2021 first_quarter PHA COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   5000 0 0 2021-04-19T17:25:45.263000-04:00
2606588 THE MATHIS HARPLE GROUP 423ff54d-3ec1-4742-aebe-222ad776abc7 Q1 THE MATHIS HARPLE GROUP 322911 PILMA 2021 first_quarter PHA Price Controls, Intellectual Property Rights HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-04-19T18:20:39.403000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2323.748ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API